NPRC/Institute
National Research Centre for Epidemiology and Microbiology; Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences; Sechenov First Moscow State Medical University
Summary of Study
Intranasal Sputnik V vaccine is a novel mucosal vaccine with immunogenic and protective properties identified by immunoglobin and neutralizing antibody production, antigen-specific T-cell response, and cytokine release.
Year Published
2022
References
PMID: 36031930 / doi: 10.1080/22221751.2022.2119169
Contact Info
Amir I. Tukhvatulin: amir_tukhvatulin@gamaleya.org
Keywords
SARS-CoV-2, vector-based heterologous vaccine, immune response, mice, primates
Coronavirus Investigated*
NHP Species
date entered
Study Type